Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Haubrich

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|October 24, 2007
Defining HIV susceptibility to new antiretroviral agents--darunavirRichard Haubrich
Expert Opinion on Pharmacotherapy|June 27, 2013
Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherenceJill Blumenthal, Richard Haubrich
Expert Opinion on Investigational Drugs|December 24, 2005
Tipranavir: a protease inhibitor for multi-drug resistant HIV-1Brookie Best, Richard Haubrich
The Journal of Infectious Diseases|August 19, 2005
CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisitedMiguel Goicoechea, Richard Haubrich
Future HIV Therapy|November 3, 2009
Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infectionJoshua J Minuto, Richard Haubrich
HIV Clinical Trials|November 4, 2008
Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008Richard Haubrich, Vincent Soriano, Alain Lafeuillade
Future Virology|December 6, 2024
Suppressed but still infectiousSara Gianella, Richard Haubrich, Sheldon R Morris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrationsMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 16, 2018
Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription databaseNimish Patel, Peter Borg, Richard Haubrich, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2020
Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCsNicolas Margot, Renee Ram, Ian McNicholl, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|October 24, 2007
Defining HIV susceptibility to new antiretroviral agents--darunavirRichard Haubrich
Expert Opinion on Pharmacotherapy|June 27, 2013
Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherenceJill Blumenthal, Richard Haubrich
Expert Opinion on Investigational Drugs|December 24, 2005
Tipranavir: a protease inhibitor for multi-drug resistant HIV-1Brookie Best, Richard Haubrich
The Journal of Infectious Diseases|August 19, 2005
CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisitedMiguel Goicoechea, Richard Haubrich
Future HIV Therapy|November 3, 2009
Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infectionJoshua J Minuto, Richard Haubrich
HIV Clinical Trials|November 4, 2008
Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008Richard Haubrich, Vincent Soriano, Alain Lafeuillade
Future Virology|December 6, 2024
Suppressed but still infectiousSara Gianella, Richard Haubrich, Sheldon R Morris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrationsMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 16, 2018
Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription databaseNimish Patel, Peter Borg, Richard Haubrich, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2020
Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCsNicolas Margot, Renee Ram, Ian McNicholl, et al.
Pageof 11